RT Book, Section
A1 Gonzalez, Blanca
A1 Wang, Luojun
A1 Campo, Elias
A2 Kaushansky, Kenneth
A2 Prchal, Josef T.
A2 Burns, Linda J.
A2 Lichtman, Marshall A.
A2 Levi, Marcel
A2 Linch, David C.
SR Print(0)
ID 1178750920
T1 Pathology of Lymphomas
T2 Williams Hematology, 10e
YR 2021
FD 2021
PB McGraw-Hill Education
PP New York, NY
SN 9781260464122
LK hemonc.mhmedical.com/content.aspx?aid=1178750920
RD 2024/04/19
AB SUMMARYThe  World  Health  Organization  (WHO)  classification  of  the  lymphocytic  neoplasms  updated  in  2016/2017  represents  a  worldwide  consensus  on  lymphoma  diagnosis  and  is  based  on  two  major  principles:  the  stratification  of  neoplasms  according  to  their  cell  lineage  and  their  derivation  from  precursor  or  mature  cells.*  The  classification  recognizes  specific  diseases  based  on  a  combination  of  morphology;  immunophenotype;  and  genetic,  molecular,  and  clinical  features.  The  WHO  classification  identifies  three  main  groups  of  lymphoid  malignancies:  B-cell  neoplasms,  T-  and  natural  killer  (NK)-cell  neoplasms,  and  Hodgkin  lymphoma.  In  addition  to  well-defined  entities,  the  classification  includes  some  provisional  entities  that  correspond  to  categories  for  which  there  was  insufficient  evidence  to  support  its  recognition  as  distinct  diseases  and  borderline  categories  with  overlapping  features  between  large  B-cell  lymphomas  and  Burkitt  or  Hodgkin  lymphoma.